Tower Research Capital LLC (Trc) Journey Medical Corp Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Journey Medical Corp stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 761 shares of DERM stock, worth $3,356. This represents 0.0% of its overall portfolio holdings.
Number of Shares
761
Previous 4,933
84.57%
Holding current value
$3,356
Previous $27,000
85.19%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding DERM
# of Institutions
40Shares Held
2.94MCall Options Held
0Put Options Held
0-
B. Riley Securities, Inc. Los Angeles, CA865KShares$3.81 Million0.36% of portfolio
-
Vanguard Group Inc Valley Forge, PA325KShares$1.43 Million0.0% of portfolio
-
Cambridge Investment Research Advisors, Inc.314KShares$1.39 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny268KShares$1.18 Million0.0% of portfolio
-
American Financial Group Inc180KShares$793,8000.44% of portfolio
About Journey Medical Corp
- Ticker DERM
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 11,596,500
- Market Cap $51.1M
- Description
- Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...